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Abstract
Background: In recent years several new fastidious bacteria have been identified that display a high specificity for BV;
however no previous studies have comprehensively assessed the behavioural risk associations of these bacterial vaginosis-
candidate organisms (BV-COs).
Methods: We examined the associations between 8 key previously described BV-COs and BV status established by Nugent’s
score (NS). We also examined the sexual practices associated with each BV-CO. We incorporated 2 study populations: 193
from a sexually-inexperienced university population and 146 from a highly sexually-active clinic population. Detailed
behavioural data was collected by questionnaire and vaginal smears were scored by the Nugent method. Stored samples
were tested by quantitative PCR assays for the 8 BV-COs: Atopobium vaginae, Gardnerella vaginalis, Leptotrichia spp.,
Megasphaera type I, Sneathia spp., and the Clostridia-like bacteria BVAB1, BVAB2 and BVAB3. Associations between BV-COs
and BV and behaviours were examined by univariate and multivariable analyses.
Results: On univariate analysis, all BV-COs were more common in BV compared to normal flora. However, only Megasphaera
type I, BVAB2, A. vaginae and G. vaginalis were significantly independently associated with BV by multivariable analysis. Six
of the eight BV-COs (Megasphaera type I, BVAB2, BVAB3, Sneathia, Leptotrichia and G. vaginalis) were rare or absent in
sexually-unexposed women, and demonstrated increasing odds of detection with increasing levels of sexual activity and/or
numbers of lifetime sexual partners. Only G. vaginalis and A. vaginae were commonly detected in sexually-unexposed
women. Megasphaera type I was independently associated with women-who-have-sex-with women (WSW) and lifetime
sexual partner numbers, while unprotected penile-vaginal-sex was associated with BVAB2 detection by multivariate analysis.
Conclusions: Four of eight key BV-COs were significantly associated with BV after adjusting for the presence of other BV-
COs. The majority of BV-COs were absent or rare in sexually-unexposed women, and associated with increasing sexual
exposure, suggesting potential sexual transmission of BV-COs.
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Introduction
Bacterial vaginosis (BV) is an enigmatic condition and despite
over 50 years of medical research, its aetiology and pathogenesis
remains unknown. It is the commonest cause of vaginal discharge
globally [1,2], is associated with adverse pregnancy outcomes
[3,4,5,6] and enhancement of heterosexual HIV transmission [7].
There is debate as to whether BV is caused by a single bacterial
agent or whether it has a polymicrobial aetiology. Gardnerella
vaginalis has been the bacterium most intensively studied in relation
to BV; however it is not specific for BV and is commonly present
in women with normal vaginal flora although usually in lower
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that a biofilm, predominantly comprised of G. vaginalis and
Atopobium vaginae is associated with BV [9], and that the presence of
these two organisms together in high copy numbers have high
sensitivity (95%) and specificity (99%) in predicting BV [10].
However, the advent of molecular screening has also identified a
number of fastidious, primarily anaerobic bacteria, in association
with BV [11,12,13,14,15,16,17], including the Clostridia-like
bacteria vaginosis-associated bacteria (BVAB) 1, 2 and 3, the
closely related lactic-acid producing Leptotrichia and Sneathia genera,
and the uncultivated Megasphaera-like phylotype (termed type I)
[13]. In particular, Fredricks found that while no one bacterial
vaginosis-candidate organism (BV-CO) was universally present in
BV, the presence of either BVAB2 or Megasphaera type I had a
sensitivity of 100% and specificity of 91.3% in predicting BV. The
causal role of these BV-COs remains to be established and there
are no published reports on their behavioural associations and
whether they are sexually transmitted.
Observational evidence shows a strong association between
sexual activity and BV [18,19,20,21,22]. In a recent meta-analysis
BV was associated with recognized STI risk factors such as
multiple sexual partners and condoms were protective against BV
[21]. We have recently reported that BV is absent in women with
no history of sexual activity with another individual, importantly
this study considered both coital and non-coital sexual activity in
their classification of sexual exposure [22,23]. There are data to
also suggest transmission of BV may occur between women
[19,21,24,25,26,27]. Women-who-have-sex-with-women (WSW)
have consistently demonstrated higher BV prevalence rates than
exclusive heterosexually active women, and consistent with the
concept of WSW transmission, studies of female-female monog-
amous couples demonstrate high concordance for BV (73–95%)
[24,28]. However, there is some evidence against the sexual
transmission of BV. Studies testing the impact of male partner
treatment have failed to consistently reduce BV recurrence in
women [29,30,31,32], and some studies have identified BV in
women who have not engaged in penile-vaginal sex [22,33,34].
Using samples from two published studies that collected detailed
behavioural data and included women with a broad range of
sexual experience including sexually-naive women, we sought to
examine the relative strength of associations between the
aforementioned key BV-COs and BV status established by
Nugent’s score (NS), and to establish the behavioural character-
istics associated with each BV-CO.
Methods
Ethics statement
The Human Research and Ethics Committee of the University
of Melbourne approved both studies incorporated into this
research. Informed written consent was obtained from all
participants involved in the study.
Study populations and recruitment methods
In order to obtain a study population with a broad range of
sexual exposure from no history of sexual activity to high levels of
sexual activity, we combined populations from two published
studies: the FUSS (Female University Student Study) [22], and a
clinic population of 342 women attending Melbourne Sexual
Health Centre (MSHC) with symptoms of vaginal discharge or
odour from July 2003–August 2004 [19]. For the FUSS study,
women aged between 17–21 years attending the University of
Melbourne, from March–July 2008 were eligible to enrol.
Advertising material was placed in the university orientation
handbook and on posters throughout the university. Study staff
also handed out advertising material at the university campus.
Advertising material directed interested women to the study
website (www.mshc.org.au/fuss/), which described the study in
detail, and provided investigators’ contact details. Research
investigators provided a detailed explanation of the study upon
contact, and a record was kept of all individuals who contacted
investigators.
FUSS contained 3 groups of women: sexually-inactive women
with no history of any sexual-contact with another person, women
with a history of non-coital contact but no penile-vaginal sex, and
women with a history of penile-vaginal sex. Overall the FUSS
population had limited sexual exposure. The clinic population was
recruited at MSHC by clinicians and the participants were
sexually-experienced women with higher numbers of lifetime
partners. This group was included to act as a comparison group to
the low risk FUSS population, to extend the breadth of sexual
exposure in the overall study population and to provide ge-
neralisable findings to past studies. Most studies of the association
of BV-COs with BV have been in women recruited from higher
prevalence populations [15,17,35,36].
Clinical methods
Participants in both studies completed questionnaires recording
demographic, medical, sexual partnership and behavioural data.
In FUSS, these data were collected via self-collected paper-based
questionnaires with the option of online questionnaires, whereas in
the clinic study women self-completed hard copy questionnaires.
Questions were asked in a standardized way across both studies to
allow these data to be aggregated where necessary. Both studies
used the Nugent method to diagnose BV on Gram-stained vaginal
smears. In FUSS they were self-collected, while they were
clinician-collected in the clinic study. FUSS participants received
clear diagrammatic instructions regarding self-collecting vaginal
swabs and smears. Self-collected smears have been shown to be
equivalent to practitioner-collected samples in published studies
[37,38] and have been extensively used in BV research.
All vaginal smears were scored using the Nugent method by an
experienced microscopist with no access to the behavioural data; a
Nugent score (NS) of 0–3 was graded as normal flora (NF), 4–6 as
intermediate flora, and 7–10 as BV. Ten percent of slides were re-
read by a second microscopist, who was blind to the original
results. If consensus was not reached, a third microscopist assessed
the slide and a discussion followed until agreement was reached.
Overall, 193 samples from FUSS were analysed including all
samples with a NS of 7–10 (n=24), all samples from women who
reported no history of penile-vaginal sex ever (n=82), and an
equivalent random sample of women who reported penile-vaginal
sex ever (n=87). From the clinic study, 146 random samples were
selected from participants reporting .10 lifetime partners (male
and female partners combined). The two study populations were
combined for this analysis in order to provide a uniquely diverse
population of women that ranged from sexually-inexperienced
(FUSS) to highly sexual experienced (clinic study). Having
behavioural data and clinical samples from women with a broad
range of sexual exposure was considered integral to investigating
the associations between BV-COs and sexual activity. Only
women with normal flora and BV were included in this analysis
and women with intermediate flora were excluded. Women who
were pregnant, HIV infected, postmenopausal, or non- fluent in
English were excluded from participating in either study. All swabs
samples used in this study were stored at 280uC until processing.
The Human Research and Ethics Committee of the University of
Melbourne approved both studies.
BV-COs: BV and Sexual Associations
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Eight BV-COs were selected including Atopobium vaginae,
Gardnerella vaginalis, Leptotrichia spp., Megasphaera type I, Sneathia
spp. and the Clostridia-like bacteria BVAB1, BVAB2, and
BVAB3; cost limited the inclusion of other BV-COs. Lactobacillus
crispatus was also included as a key indicator of normal vaginal flora
status. Total DNA was extracted from 200 ml volumes of the
resuspended vaginal swab samples using the MagNA Pure LC
system (Roche Diagnostics) with the DNA Isolation Kit I protocol,
eluting in a final volume of 100 ml with DNA stored at 220uC
until testing. Included in each DNA extraction run were controls
that included human A549 cells and DNA-free phosphate buffered
saline. To assess inhibition, sample adequacy and integrity, real-
time PCR amplification and detection of the human b-globin gene
was carried out as previously described [39]. Sample DNA was
then subjected to a series of quantitative PCR (qPCR) TaqMan-
based assays, targeting various bacterial 16S rRNA gene targets.
All assays were performed on the LC480 real-time instrument
(Roche Diagnostics) using 5 ml DNA in a 20 ml reaction. Assays
developed by Fredricks et al. [40] were used to detect A. vaginae, L.
crispatus, Leptotrichia spp., Megasphaera type I, and the Clostridia-like
bacteria BVAB1, BVAB2, and BVAB3 with the detection for
Leptotrichia spp. and Sneathia spp. carried out as separate reactions.
G. vaginalis detection was determined by an assay by Zariffard et al.
[41]. Positive controls consisting of extracted DNA from culture or
plasmids were included in each run as well as appropriate no
template controls.
Statistical analysis
The associations between BV-COs and BV were assessed by
univariate and multivariate analyses using logistic regression. The
presence of BV-COs according to sexual exposure variables were
examined using Chi square tests or Fisher’s exact where
appropriate. To investigate the association between behavioural
risk factors and BV-COs, a multivariate logistic regression model
was constructed, including variables with a significance of p,0.05
from the univariate analysis and key risk factors for BV from
published literature. These included: number of lifetime vaginal
sexual partners (LSP), smoking, age, frequency of vaginal sex and
frequency of receptive oral sex and unprotected vaginal sex
(UPVSI) in the last 12 months. Samples with intermediate flora
(Nugent’s score 4–6) were not included in this analysis and all
analysis was undertaken using PASW software (version 18).
Results
Overall, 339 specimens were analysed; 193 from FUSS and 146
from the clinic cohort. Among the study population, 233 women
had NF and 106 women had BV. Table S1 describes the
demographic and behavioural characteristics of the study popula-
tions. As expected, more clinic-based women were older, more
sexually-experienced,more likelytosmokecigarettes (p,0.001),but
they were less likely report sex toy use (p=0.02) than FUSS
participants. The study populations were similar with respect to
other reported practices including oral contraception use and
douching.
Associations between candidate organisms with
bacterial vaginosis and normal flora
The association between detection of BV-COs in BV and NF
were examined, Table S2. All BV-COs except BVAB1 were
significantly more common in women with BV than NF; while
BVAB1 was absent in NF and uncommon in BV. L. crispatus was
significantly more common in NF than BV. In a logistic regression
model, Megasphaera type I demonstrated the strongest independent
association with BV of the 8 BV-COs [Adjusted Odds ratio
(AOR)=15.4; 95% CI 5.9–40.2, p,0.001, Table S2]. Three
other BV-COs: BVAB2, A. vaginae and G. vaginalis were also
significantly independently associated with BV (range of
AORs=4.1 to 15.3, Table S2), and although the AORs for
BVAB3, Leptotrichia and Sneathia exceeded 1.0, the association was
not statistically significant once adjusted for the other BV-COs.
Despite having a protective effect against BV, the additional of L.
crispatus to the adjusted analysis did not significantly change the
associations shown in Table S2 (data not shown).
Associations between sexual exposure and BV-COs in
women with normal flora and BV
The association between BV-COs and differing degrees of
sexual exposure was examined separately in women with NF and
BV using two measures: reported sexual exposure categories and
numbers of lifetime sexual partners (LSP), Table S3. Sexual
exposure was classified according to three categories: i) no sexual
contact with another individual, ii) non-coital sex only and/or
100% condom use for all vaginal sex ever and iii) unprotected
vaginal sex ever. Non-coital sex and 100% condom use were
combined to restrict the number of total categories and we found
the women who reported 100% protected sex were behaviourally
closer to those with only non-coital exposure with regard to sexual
risk behaviours. Number of LSP was classified as 0, #10 and .10.
Importantly, six of the eight BV-COs: Sneathia, BVAB1, BVAB2,
BVAB3, Leptotrichia and Megasphaera type I, were either absent or
rare in women with no reported history of sexual exposure,
whereas G. vaginalis was detected in 28% and A. vaginae in 71% of
sexually-unexposed women. Most of the BV-COs demonstrated
an increase in detection with increasing sexual exposure measured
by either the 3 exposure categories or by increasing number of
lifetime sexual partners in NF and/or BV (Table S3). A. vaginae
demonstrated least association with sexual risk with no association
found with increasing sexual exposure categories in normal flora, a
reverse association with lifetime partners in normal flora, and only
a trend towards an association with increasing sexual exposure and
BV.
Associations between BV sexual behavioral risk factors
and BV-COs
To further investigate the epidemiology of BV-COs, the
association of BV sexual risk factors with each BV-CO was
examined. BV risk factors included in the analysis included LSP
number, UPVSI in the last 12 months, reporting a female partner
(WSW) in the last year, age, smoking and frequent penile-vaginal
sex and frequent receptive oral sex (.once weekly). The
associations between each of these risk variables and each BV-
CO was examined separately and adjusted for BV status (Table
S4).
Univariate analysis demonstrated that Sneathia, Leptotrichia,
Megasphaera type I, G. vaginalis, BVAB2 and BVAB3 were
significantly associated with having .10 LSP or UPVSI or both
factors after adjustment for BV status. Frequent sexual activity
(vaginal and/or receptive oral) was related to increased detection
of Sneathia, Leptotrichia, G. vaginalis, and BVAB3, while Megasphaera
type I and Leptotrichia were significantly associated with WSW
status. BVAB1 was uncommon and no associations could be
examined with meaningful statistical power (Table S4). The
association between BV-COs and other behavioural and demo-
graphic variables such as anal sex, douching, oral contraceptive
pill, country of birth, circumcision status of partner and past
BV-COs: BV and Sexual Associations
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associations.
Behavioural associations with Megasphaera type I, G.
vaginalis, BVAB2 and A. vaginae by multivariate analysis
As Megasphaera type I, G. vaginalis, BVAB2 and A. vaginae were
significantly associated with BV status after adjustment for the
presence of other BV-COs, we further explored the behavioural
associations with these four BV-COs by multivariate analysis.
Variables entered into the model included LSP number, UPVSI in
the last 12 months, reporting a female partner (WSW) in the last
year, age, smoking, frequent penile-vaginal sex and frequent
receptive oral sex (.once weekly) and BV status, Table S5. By
multivariable analysis Megasphaera type I was independently
associated with WSW (AOR=4.4; 95%CI 1.2–16.4, p=0.03)
and having more than 10 LSP (AOR=2.9; 95% CI 1.0–8.3,
p=0.04), and BVAB2 showed a strong independent association
with unprotected penile-vaginal sex in the last 12 months (AOR
22.5; 95% CI 2.6–196.0, p=0.005); while no specific behaviours
remained significantly associated with G. vaginalis or A. vaginae by
multivariate analysis.
Discussion
Our paper explores the association between eight key BV-COs
with BV and examines their sexual risk factors; Table S6
summarizes our major findings. Seven of the eight BV-COs
demonstrate a strong unadjusted association with BV, and confirm
other studies’ findings [8–14]. Four of the eight BV-COs
(Megasphaera type I, BVAB2, A. vaginae and G. vaginalis) were
significantly associated with BV after logistic regression analysis,
while BVAB3, Sneathia and Leptotrichia spp. were not, and BVAB1
was too uncommon to meaningfully comment on. Six of the eight
BV-COs demonstrated significant associations with increasing
sexual exposure (Megasphaera type I, BVAB2, BVAB3, Sneathia spp.,
Leptotrichia spp. and G. vaginalis), and only two BV-COs, A. vaginae
and G. vaginalis, were commonly detected in women with no sexual
experience. Our findings suggest that there may be a gradient of
importance among the eight BV-COs based on their strength of
association with BV and their epidemiological association with
increasing sexual exposure. The finding that the majority of BV-
COs were absent or rare in sexually-unexposed women and
associated with increasing sexual exposure suggest sexual trans-
mission of BV-COs is occurring.
For agents to be causative of BV one would anticipate that they
would be absent in NF and universally present in BV; no single
BV-CO in our study satisfied both these criteria. We have shown,
however, that Megasphaera type I and BVAB2 were both strongly
associated with BV and were also rare or absent in sexually-naive
women. The suggestion that Megasphaera type I and BVAB2 are
key BV-COs is supported by Fredricks et al. who showed that the
combination of BVAB2 and/or Megasphaera type I conferred the
best BV diagnostic predictability for BV (sensitivity 98.8%,
specificity 88.5%) [15].
The other BV-COs which were significantly associated with BV
were G. vaginalis and A. vaginae, bacteria known to be integrally
related to BV disease; however these BV-COs were also detected
at lower loads in women with NF (data not shown). G. vaginalis has
long been implicated in the development of BV and recent
published findings have suggested that G. vaginalis biofilms may be
critical in BV pathogenesis and symptomatology [42,43]. Our
results demonstrating that G. vaginalis was ubiquitous in women
with BV, and further analysis indicating a 6–7 log10 greater
bacterial load in BV than NF (data not shown), are consistent with
historical findings [10,44]. Our data also show that G. vaginalis was
relatively common in truly virginal women (prevalence 28%);
however the prevalence of G. vaginalis increased dramatically with
numbers of sexual partners, indicating that sexual activity or
transmission contributes to increasing detection of G. vaginalis.
Studies using enzyme assays to identify G. vaginalis biotypes and
genomic comparisons of G. vaginalis isolates suggest particular
strains of G. vaginalis may have differing pathogenic properties,
such as biofilm formation [45]. Whether differing biotypes of G.
vaginalis are present in sexually-inexperienced compared to
experienced women is not known and would be of considerable
interest.
A. vaginae was independently associated with BV and whilst also
commonly seen in those with NF (62%), it was generally at low
loads (,4 log10, data not shown). The relatively high prevalence of A.
vaginae in NF samples was similar to that of Menard et al [10] at
69%, but significantly higher than a previous publication that
detected A. vaginae in 12% of NF [46]. A key difference is that in
the current study, our assay used primers described by Fredricks et
al. [40] which target a 81-bp region of the 16S rRNA gene, whilst
the assay in the earlier publication targeted a 430-bp region [47].
Generally, the longer amplicon assay displays relatively reduced
sensitivity, and the difference in sensitivities between these two
assays is discussed in detail by Menard [10]. A. vaginae, like G.
vaginalis, was detected in sexually-inactive women, but unlike
G. vaginalis, A. vaginae showed no significant association with
increasing sexual exposure.
Importantly, our data seem to indicate that Leptotrichia and
Sneathia spp. are not associated with BV once adjusted for the
presence of other BV-COs, and their strong relationship with
increasing sexual risk was seen similarly in women with NF and
BV. This could be important, because if a BV-CO is sexually
transmitted but not associated with disease causation, then one
would expect to see increasing prevalence with increasing sexual
risk equally in both BV and NF. This was the case for Sneathia and
Leptotrichia spp. but not for any of the other BV-COs. Collectively
these findings suggest that Sneathia and Leptotrichia spp. could just be
epidemiologically associated with BV, or sexually transmitted
‘‘passengers’’ rather than being involved in the development of
BV; a similar scenario to that of some Ureaplasma and Mycoplasma
spp. in NGU [48]. However, as Sneathia and Leptotrichia spp. were
detected in 74 and 73 percent of BV cases in our study
respectively, their role in symptom/disease pathogenesis, especial-
ly in a polymicrobial disease context, cannot be excluded. Future
work involving the exploration of metabolic interactions between
BV-COs will assist in further understanding the contribution of
these organisms to the development of BV.
Our data show that Megasphaera type I may have distinctive
behavioural risk factors. Although we only had 12% of participants
with a female partner in the last 12 months, these women
demonstrated a strong association with Megasphaera type I
detection. It is important to note that WSW have greater BV
population prevalence than other women [21,24,27,49,50] and the
high prevalence of BV in WSW has to date remained unexplained.
We note with interest that Fredricks et al. [15] found Megasphaera
type I detection was highly sensitive for BV (94.5; 95%CI 86.7–
97.9) in a population of women with a history of sexual contact
with another woman. In our study Megasphaera type I was 91.3%
(95%CI 70.4–98.4) sensitive for BV in WSW, but only 72.2%
(95%CI 61.2–81.2) sensitive for BV in non-WSW. It is possible
that Megasphaera type I may be an important BV-CO in the
development of BV in WSW, and that WSW with BV differ in
their microbiological BV profile to other women. Clearly larger
prospective studies are needed to better understand this relation-
BV-COs: BV and Sexual Associations
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our knowledge has not been previously described.
This study has several limitations. We used a study population
that combined samples from two previous studies collected at
different time points. One group was a symptomatic clinic-based
population; the other a lower risk university population. By
combining these populations investigators were able to obtain a
uniquely diverse population of women who ranged from sexually-
inexperienced to highly sexually-experienced, and we considered
this necessary to be able to comprehensively address the
contribution of BV-COs to sexual activity. Prior published studies
investigating the association of BV-COs with BV have not
contained women with limited or no sexual exposure. The fact
that these populations substantially differ in their risk profile,
however, is also limitation of the study. We have adjusted for
lifetime sexual partner number in the multivariable analyses to
control for the key differences in sexual exposure in the study
groups, and although we describe known differences in the two
study populations not all differences between the groups may not be
accounted for. Questions were asked in a standardized way in both
studies to allow these data to be aggregated where necessary, and
self-collected paper-based questionnaires were used for both studies
with the option of an identical self-completed online questionnaire
for FUSS (40% of FUSS participants used online surveys). Self-
sampling was employed in FUSS and clinician-collected samples
were used in the clinic study; published studies confirm equivalency
of self-collected to clinician-collected samples for the diagnosis of
BV, and excellent agreement has been reported between self-
collected versus clinician-collected swabs for molecular quantifica-
tion (qPCR) of BV-associated bacteria [37,38]. Specimens were
stored in the same way in both studies as whole samples at 280uC,
and we confirmed the integrity of stored samples in both studies.
Due to funding limitations, our use of molecular methods to
characterise the vaginal bacterial communities was limited to a
representative panel of eight of the most promising and specific
BV-COs, acknowledging there is an increasing number of BV-
COs being cited in the literature, particular from next-generation
sequencing projects [51,52]. Further research should include a
greater number of BV-COs and in particular more Megasphaera
spp. including the type II phylotype. Our data was cross-sectional,
therefore we have no capacity to comment on temporal
relationships between the detection of BV-COs and sexual
behaviour, and we can only make inferences regarding BV
causality and pathogenesis. Due to the complexity of the current
analyses in this manuscript, we also did not include possible
metabolic interactions between species in this study, and have
limited ourselves to exploring the associations between individual
BV-COs and behaviour and BV disease status. Given the
polymicrobial nature of BV, assessing for metabolic interactions
is the subject of further research by investigators. Another
limitation of cross-sectional data is that fluctuations in vaginal
flora are known to occur rapidly and to be influenced by various
factors including hormonal variation and day-to-day behaviours
[53]., clearly longitudinal studies with frequent sample collection
are required to further understand the complex relationship
between BV-COs and development of BV. As with all BV
research, the lack of a gold standard test hampers our ability to
explore specific disease associations. We excluded any women with
intermediate vaginal flora (NS4-6) in an attempt to minimize the
possible misclassification of flora caused by a cross-sectional
‘snapshot’ design in an actively changing environment. It is
important to also note that this data cannot be used to determine
the population prevalence of any of the BV-COs as the sampling
method was not appropriate for this.
The strengths of our study design include the systematic
objective assessment using Nugent’s method of all vaginal smears
by an experienced microbiologist and 10% being re-scored by an
alternative microscopist. Not all studies examining the role of BV-
COs in BV have applied methods such as the Nugent method to
classify flora objectively and some have used more subjective
clinical descriptions and/or patient history [12,14,16]. Another
important strength of our research is that highly detailed
behavioural data was collected and the FUSS study was quite
unique, including women with a broad-range of sexual experience,
in particular a considerable number with no reported sexual
exposure to another person or limited non-coital exposure only.
Previous BV study populations that have examined BV-COs have
recruited women from STD clinics or women from high
prevalence populations. The inclusion of sexually-naive women
in our study, in addition to comprehensive, confidential sexual
behaviour data from participants, has enabled us to explore
specific sexual practices and their associations to individual BV-
COs in considerable depth.
Conclusion
These study data contribute to the developing collective
understanding of BV-related bacteria and their role in BV
pathogenesis. Megasphaera type I, BVAB2, A. vaginae and G. vaginalis
were significantly associated with BV after adjusting for detection
of other BV-COs; however, BVAB3, Sneathia and Leptotrichia spp.
showed no independent association with BV, and BVAB1 was
absent in NF and uncommon in BV. Our data show that six of the
eight BV-CO were rare or absent in sexually-inactive women:
Sneathia spp., Leptotrichia spp., Megasphaera type I, BVAB1, BVAB2
and BVAB3. G. vaginalis and A. vaginae were the only BV-COs
detected commonly in sexually-inexperienced women. After
multivariate-analysis Megasphaera type I was independently associ-
ated with WSW and lifetime sexual partner numbers, while
unprotected vaginal sex was strongly related to detection of
BVAB2. The finding that the majority of BV-COs were absent or
rare in sexually-unexposed women, and associated with increasing
sexual activity with other individuals, suggests sexual transmission
of BV-COs is occurring. Longitudinal studies of BV and BV-COs,
and consideration of metabolic interactions between BV-COs, will
further elucidate the complex microbiology involved in the
development of BV in different populations.
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